Immediate and Delayed Procedural Stroke or Death in Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis

BACKGROUND AND PURPOSE—Stenting for symptomatic carotid stenosis (carotid artery stenting [CAS]) carries a higher risk of procedural stroke or death than carotid endarterectomy (CEA). It is unclear whether this extra risk is present both on the day of procedure and within 1 to 30 days thereafter and...

Full description

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2018-11, Vol.49 (11), p.2715-2722
Main Authors: Müller, Mandy D, von Felten, Stefanie, Algra, Ale, Becquemin, Jean-Pierre, Brown, Martin, Bulbulia, Richard, Calvet, David, Eckstein, Hans-Henning, Fraedrich, Gustav, Halliday, Alison, Hendrikse, Jeroen, Gregson, John, Howard, George, Jansen, Olav, Mas, Jean-Louis, Brott, Thomas G, Ringleb, Peter A, Bonati, Leo H
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND AND PURPOSE—Stenting for symptomatic carotid stenosis (carotid artery stenting [CAS]) carries a higher risk of procedural stroke or death than carotid endarterectomy (CEA). It is unclear whether this extra risk is present both on the day of procedure and within 1 to 30 days thereafter and whether clinical risk factors differ between these periods. METHODS—We analyzed the risk of stroke or death occurring on the day of procedure (immediate procedural events) and within 1 to 30 days thereafter (delayed procedural events) in 4597 individual patients with symptomatic carotid stenosis who underwent CAS (n=2326) or CEA (n=2271) in 4 randomized trials. RESULTS—Compared with CEA, patients treated with CAS were at greater risk for immediate procedural events (110 versus 42; 4.7% versus 1.9%; odds ratio, 2.6; 95% CI, 1.9–3.8) but not for delayed procedural events (59 versus 46; 2.5% versus 2.0%; odds ratio, 1.3; 95% CI, 0.9–1.9; interaction P=0.006). In patients treated with CAS, age increased the risk for both immediate and delayed events while qualifying event severity only increased the risk of delayed events. In patients treated with CEA, we found no risk factors for immediate events while a higher level of disability at baseline and known history of hypertension were associated with delayed procedural events. CONCLUSIONS—The increased procedural stroke or death risk associated with CAS compared with CEA was caused by an excess of events occurring on the day of procedure. This finding demonstrates the need to enhance the procedural safety of CAS by technical improvements of the procedure and increased operator skill. Higher age increased the risk for both immediate and delayed procedural events in CAS, mechanisms of which remain to be elucidated. CLINICAL TRIAL REGISTRATION—URLhttps://clinicaltrials.gov. Unique identifierNCT00190398. URLhttp://www.isrctn.com. Unique identifierISRCTN57874028. URLhttp://www.isrctn.com. Unique identifierISRCTN25337470. URLhttps://clinicaltrials.gov. Unique identifierNCT00004732.
ISSN:0039-2499
1524-4628
DOI:10.1161/STROKEAHA.118.020684